Jeff Fairman, VP, Research at Vaxcyte, Inc. (PCVX), sold 9,238 shares at $22.50 ($208K) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market sale of $208k PCVX by VP, Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 4,619 | $104K | 50.0% |
| 2 | $22.50 | 4,619 | $104K | 50.0% |
| Total | $22.50 avg | 9,238 | $208K | 100% |
| Filing → |
| PCVX | SELL | 2022-09-07 | $257K | — | Filing → |
| PCVX | SELL | 2022-08-05 | $384K | — | Filing → |
| PCVX | SELL | 2022-05-24 | $105K | — | Filing → |